Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
3
×
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
3
×
cancer
cancer immunotherapy
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
car-t immunotherapy
deals
eli lilly
fda
investing
johnson & johnson
medical device
merck
What
companies
3
×
bio
drug
nash
new
news
roundup
approval
approved
biogen’s
biopharmaceutical
biotechs
club
continued
convo
crop
digital
disease
earlier
epidemic
exceeded
failures
fatty
fda
firms
frenzied
group
growing
haul
ipo
joined
known
latest
led
life
littered
liver
merck
met
million
Language
Current search:
companies
×
" bristol-myers squibb "
×
" boston blog main "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M